ATI RN Pharmacology 2023 retake 1 | Nurselytic

Questions 59

ATI RN

Home > ATI RN > ATI Pharmacology > ATI RN Pharmacology 2023 retake 1
ATI RN Test Bank

ATI RN Pharmacology 2023 retake 1 Questions

Extract:


Question 1 of 5

A nurse is providing teaching to a client who has a new prescription for carbamazepine for the treatment of seizures. The nurse should instruct the client to monitor for which of the following adverse effects?

Correct Answer: B

Rationale: The correct answer is B: Blurred vision. Carbamazepine is known to cause visual disturbances, including blurred vision, diplopia, and nystagmus. The nurse should instruct the client to monitor for any changes in vision and report them promptly to the healthcare provider. Insomnia (choice
A) is not a common adverse effect of carbamazepine. Tachypnea (choice
C) refers to rapid breathing and is not typically associated with carbamazepine use. Metallic taste (choice
D) is not a common adverse effect of carbamazepine either.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

A nurse is caring for a client who is mechanically ventilated and receiving propofol intravenously. Which of the following manifestations should the nurse identify as a complication of administration?
A nurse is providing teaching to a client who has a new prescription for rifampin. Which of the following statements should the nurse include in the teaching?
A nurse is reviewing a client's medical history before administering a new prescription for atropine. Which of the following client conditions is contraindicated?
A nurse is caring for a client who is receiving vancomycin by IV infusion over 30 min. Which of the following findings indicate the client experiencing a vancomycin infusion reaction?
A nurse is caring for a client who develops an anaphylactic reaction to IV antibiotic administration. After assessing the client's respiratory status and stopping the medication infusion, which of the following actions should the nurse take next?

Access More Questions!

ATI RN Basic

$89/ 30 days

 

ATI RN Premium

$150/ 90 days